Curio Wealth LLC Has $62,000 Stock Holdings in SPDR S&P Biotech ETF $XBI

Curio Wealth LLC raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 74,700.0% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 748 shares of the exchange traded fund’s stock after purchasing an additional 747 shares during the quarter. Curio Wealth LLC’s holdings in SPDR S&P Biotech ETF were worth $62,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in XBI. DHJJ Financial Advisors Ltd. acquired a new position in SPDR S&P Biotech ETF during the second quarter worth $25,000. Garrison Bradford & Associates Inc. bought a new position in SPDR S&P Biotech ETF during the first quarter worth about $39,000. Compass Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 46.0% during the first quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after buying an additional 200 shares during the last quarter. Golden State Wealth Management LLC boosted its stake in shares of SPDR S&P Biotech ETF by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after acquiring an additional 319 shares during the period. Finally, Avalon Trust Co acquired a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $57,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $108.39 on Friday. The business has a fifty day simple moving average of $98.08 and a two-hundred day simple moving average of $87.88. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $110.96. The company has a market capitalization of $6.65 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.